Treatment patterns and humanistic burden of malignant pleural mesothelioma in Spain
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03591-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Susana Cedres und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitari de La Vall d'Hebron, Barcelona, Spain. Hauptthemen laut MEDLINE: Pleural Neoplasms, Cost of Illness, Mesothelioma, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Malignant pleural mesothelioma (MPM) is an aggressive cancer with long latency and poor prognosis. The real-world treatment patterns and humanistic burden of MPM in an international cohort of patients were recently published. Spanish data are currently lacking and are reported here. Methods/Patients Data were collected from three sources: physician-abstracted demographic, clinical and treatment characteristics of patients with MPM; patient-completed questionnaires on treatment satisfaction, symptoms, caregiver use, and impact of the disease; and caregiver-completed questionnaire reporting their activity and its impact on their daily life.
Results
The 241 patients in Spain were primarily elderly (median age: 67 years), male, retired/unemployed/on long-term sick leave, and diagnosed at stage IV with unresectable disease. Exposure to asbestos was detected (54%, 101/188). First-line treatment (1L) consisted primarily of doublet chemotherapy (86%, 207/241). Of 102 patients who completed 1L at data abstraction, 67 were receiving maintenance therapy, most commonly singlet chemotherapy with pemetrexed. Best supportive care was given to 29 patients, primarily after 1L (86.2%, 25/29). Symptom burden was high and health-related quality of life was poor and declined with progression: mean (SD) EQ-5D score and EQ-5D visual analogue scale score were 0.615 (0.285) and 60.8 (17.1) in 1L and 0.497 (0.370) and 56.1 (19.5) in second line. Overall, 67% of patients (162/241) required daily assistance from their caregiver, who reported an impact on their psychological well-being.
Conclusions
Patients with MPM in Spain were overall treated according to treatment guidelines at the time. Nevertheless, a considerable burden of disease was reported by patients and caregivers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Universitari de La Vall d'Hebron, Barcelona, Spain.
- Hospital Universitario Puerta del Mar, Cádiz, Spain.
- Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Macclesfield, Cheshire, UK.
- Bristol Myers Squibb, Madrid, Spain. nestor.alvarez@bms.com.
- Bristol Myers Squibb, Madrid, Spain.
- Bristol Myers Squibb, Braine L'Alleud, Belgium.
Zitieren
APA
Cedres, S., Calvete, J., Taylor-Stokes, G., Ayerza, N. Á., Larena, D. V., & Daumont, M. (2024). Treatment patterns and humanistic burden of malignant pleural mesothelioma in Spain. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03591-5
Vancouver
Cedres S, Calvete J, Taylor-Stokes G, Ayerza NÁ, Larena DV, Daumont M. Treatment patterns and humanistic burden of malignant pleural mesothelioma in Spain. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03591-5
BibTeX
@article{Cedres2024,
author = {Cedres, Susana and Calvete, Julio and Taylor-Stokes, Gavin and Ayerza, Néstor Álvarez and Larena, David Vilanova and Daumont, Melinda},
title = {Treatment patterns and humanistic burden of malignant pleural mesothelioma in Spain},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03591-5}
}
EUVIMED